It was also discovered that A2AR knockout significantly contributed to immunosuppressive effects in CAR T cells, compared to A2BR genetic abrogation, rendering A2AR as the major target for tumor immunotherapy. The gene discussed is ADORA2A; the disease is neoplasm.